tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Beam Therapeutics: Promising BEACON Trial Results Support Buy Rating
PremiumRatingsBeam Therapeutics: Promising BEACON Trial Results Support Buy Rating
24d ago
Beam reports updated data from BEACON Phase 1/2 trial of ristoglogene
Premium
The Fly
Beam reports updated data from BEACON Phase 1/2 trial of ristoglogene
25d ago
Beam Therapeutics rises 11.3%
Premium
The Fly
Beam Therapeutics rises 11.3%
29d ago
FDA appoints Richard Pazdur as Director of CDER
PremiumThe FlyFDA appoints Richard Pazdur as Director of CDER
2M ago
Beam Therapeutics: Promising Gene Editing Advances Justify Buy Rating
Premium
Ratings
Beam Therapeutics: Promising Gene Editing Advances Justify Buy Rating
2M ago
Cathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat
Premium
Market News
Cathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat
2M ago
Cathie Wood Steps Up Bet on Bullish Stock (BLSH), Trims Stake in Palantir (PLTR) amid Strong Q3 Earnings
PremiumMarket NewsCathie Wood Steps Up Bet on Bullish Stock (BLSH), Trims Stake in Palantir (PLTR) amid Strong Q3 Earnings
2M ago
Beam Therapeutics reports Q3 EPS ($1.10), consensus ($1.03)
Premium
The Fly
Beam Therapeutics reports Q3 EPS ($1.10), consensus ($1.03)
2M ago
Promising Potential of BEAM-101 in Sickle Cell Treatment Justifies Buy Rating
Premium
Ratings
Promising Potential of BEAM-101 in Sickle Cell Treatment Justifies Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100